IMTX · Immatics N.V.
Market Cap
$1.42B
Shares
152.23M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.45
Open$9.68
Day$9.32–9.89
52W close$5.09–11.87
Avg vol 30d519K
Short int4.9M · 3.2% float · 14.9d
Short vol14%
DataJan 2020–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−6%
below
Price vs 50-day avg
+0%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
64%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+9%
trailing
6-month return
−6%
trailing
YTD return
−10%
this year
Relative strength
−19%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $9 › 200d $10 — 200d above 50d
Institutional flow
Distributing
-1% holders QoQ · +12 funds added
Insider flow
Accumulating
Net +$7.5M over 90 days · 0% sells
Short interest
Falling
3.23% of float · ▼ -2.1% MoM · 14.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
83 holders — mid 3-yr range
Squeeze score
58
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
63%
annualized · 1-yr
Max drawdown
−28%
past year
ATR
5.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−6%
Bearish
Price vs 50-day avg
+0%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
64%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $9 › 200d $10 — 200d above 50d
Institutional flow
Distributing
-1% holders QoQ · +12 funds added
Insider flow
Accumulating
Net +$7.5M over 90 days · 0% sells
Short interest
Falling
3.23% of float · ▼ -2.1% MoM · 14.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
83 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $5
Now $9 · 64%
Range high $12
vs 200-day avg -6%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMTX
this stock
Immatics N.V.
|
$1.42B | -10.0% | — | — | 3.2% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +19.5% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.27B | +2.9% | +20.8% | 19.6 | 2.3% |
|
ARGX
Argenx SE
|
$63.63B | +21.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.92B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Earnings & Events
Investor Relations
Latest news
Immatics Announces $150 Million U…
- Published
- Aug 25, 2026
- Upcoming events
- 4
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMTX | +5.8% | +9.1% | -5.5% | +9.1% | -10.0% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +5.4% | +6.1% | -18.9% | +6.1% | -22.8% |
Key facts
CIK
1809196
CUSIP
N44445109
13F (30d)
81 filings
79 filers
Visit website
Investor relations